OXFD - Oxford Immunotec Global PLC

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
72,832
73,710
59,753
103,080
86,078
Cost of Revenue
18,664
19,288
16,826
46,731
39,472
Gross Profit
54,168
54,422
42,927
56,349
46,606
Operating Expense
62,514
59,435
60,574
85,083
72,026
Operating Income
-8,346
-5,013
-17,647
-28,734
-25,420
Net Non Operating Interest Income Expense
3,666
4,247
-1,797
-3,105
-864
Other Income Expense
-1,045
-2,991
-5,337
588
161
Pretax Income
-5,725
-3,757
-24,781
-31,251
-26,123
Tax Provision
-671
-2,417
-37,286
1,634
-3,774
Net Income Common Stockholders
-6,340
-1,809
120,779
-32,885
-22,349
Diluted NI Available to Com Stockholders
-6,340
-1,809
120,779
-32,885
-22,349
Basic EPS
-
-
0.0047
-0.0014
-0.001
Diluted EPS
-
-
0.0046
-0.0014
-0.001
Basic Average Shares
-
-
25,983
23,758
22,354
Diluted Average Shares
-
-
26,568
23,758
22,354
Total Operating Income as Reported
-9,357
-6,123
-20,719
-53,587
-25,977
Total Expenses
81,178
78,723
77,400
131,814
111,498
Net Income from Continuing & Discontinued Operation
-6,340
-1,809
120,779
-32,885
-22,349
Normalized Income
-4,071
1,138
16,608
-33,531
-23,040
Net Interest Income
3,666
4,247
-1,797
-3,105
-864
EBIT
-8,346
-5,013
-17,647
-28,734
-25,420
EBITDA
-6,597
-
-
-
-
Reconciled Cost of Revenue
18,664
19,288
16,826
46,731
39,472
Reconciled Depreciation
1,749
1,753
1,662
4,240
3,094
Net Income from Continuing Operation Net Minority Interest
-5,054
-1,340
12,505
-32,885
-22,349
Total Unusual Items Excluding Goodwill
-1,113
-3,059
-5,066
797
807
Total Unusual Items
-1,113
-3,059
-5,066
797
807
Normalized EBITDA
-5,484
-201
-10,919
-25,291
-23,133
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-130.4494
-581.21
-962.54
151.43
116.208